In sub-Saharan Africa, women carry a disproportionate burden of the Human
Immunodeficiency Virus Type 1 (HIV-1) pandemic. The high risk of HIV
acquisition in these women and the variability in their disease progression is
not fully understood. Natural Killer (NK) cells, which are innate immune
antiviral lymphocytes, present systemically and at mucosal surfaces, may play
a role in preventing HIV acquisition and/or altering disease progression, as
they are key early mediators of the response to viral infections and are
equipped to kill infected cells.
The purpose of this study was to evaluate the role of NK cells in HIV-1
acquisition and following acquisition, in disease progression.
The study participants were selected women who were participating in a
randomized controlled trial assessing the effectiveness of 1% Tenofovir gel in
preventing HIV-1 (CAPRISA 004 trial). The study design was a case-control
study nested within the cohorts followed up in the CAPRISA 004 trial. In this
trial, 889 sexually-active women aged 18-40 years were randomized to
receive Tenofovir or placebo gel and prospectively followed. Assessment of
HIV infection was performed monthly by rapid HIV-1 antibody tests,
supplemented by HIV-1 RNA polymerase chain reaction (PCR), p24 Western
blotting and/or ELISA. Samples obtained prior to the first positive rapid
antibody test were retrospectively tested by HIV specific PCR to identify
window period infections. The date of infection in this study was estimated as
the midpoint between the last negative and first positive antibody test, or 14
days prior to the first HIV-1 RNA-PCR positive result. Multi-parametric flow
cytometry techniques developed and validated in healthy blood donors were
used to asses the bidirectional relationship between NK cells and HIV-1. To
simulate in vivo interaction between NK cells and autologous HIV infected
cells, an in vitro infection and coculture assay was used in addition to
conventional assays of NK cell recognition of HLA-deficient cell lines. These
were supplemented with measurement of plasma cytokines by Luminex and
microbial products by ELISA. In this study, 44 cases who acquired HIV-1 were
sampled prior to infection and 39 controls who remained HIV-1 negative
despite high behavioural exposure at the timepoint when their preceding
sexual activity was highest. To understand how HIV infection affected NK
cells during early HIV-1 infection, the first sample obtained after acquisition
was studied and compared to preinfection samples from the same participant.
The case and control groups were broadly similar in the proportions using
tenofovir gel, proportions infected with HSV-2 and number of sexual partners
but tended to be marginally older than cases (27.6 vs 23.3 years). By design
control women had higher sexual activity than cases (mean 11 vs. 5.7 sex
acts per month).
The frequency of IFN-γ secreting NK cells from women who acquired HIV
infection were significantly lower than from women who remained uninfected
in response to 721 cells-an EBV transformed B cell line (background-adjusted
median 13.7% vs. 21.6%; p=0.03) and to autologous HIV infected T-cells
(background-adjusted median 0.53% vs. 2.09%; p=0.007). NK cells from HIV
acquirers displayed impaired proliferation but enhanced spontaneous
degranulation compared with non-acquirers after co-culture with HIV
uninfected or infected autologous T-cell blasts. Adjusting for age, gel arm,
HSV-2 infection status and levels of NK cell activation, IFN-γ+ NK cell
responses to autologous HIV infected cells were associated with reduced
odds of HIV acquisition (OR 0.582; 95% CI 0.35-0.98; p=0.04). In addition,
even in the absence of ex vivo stimulation, HIV acquirers had higher levels of
generalised innate immune activation measured by systemic cytokine
concentrations (TNF-α, IL2, IL-7 and IL12p40), peripheral blood platelet
concentrations (p=0.038), and non-specific ex vivo NK cell activation
(p<0.001). Generalised NK cell activation measured directly ex vivo without
stimulation was associated with acquisition. Further, if innate immune
activation was assembled as a principal component in an unsupervised
fashion but taking into account all the measures made, it was significantly
associated with HIV acquisition (OR adjusted for age, tenofovir gel use, and
HSV-2 status for PC with innate immune factor loadings 11.27; 95% CI 1.84-
69.09; p=0.009). The causes of preinfection innate immune activation could
not be established in this study but the degree of activation could not be
explained by microbial translocation as both HIV acquirers and non-acquirers
had similar levels of plasma lipopolysaccharide (LPS), soluble CD14 (sCD14)
and intestinal fatty-acid binding protein (I-FABP). Similarly, both HIV acquirers
and non-acquirers had similar NK cell and cytokine responses to Toll-like
Receptor (TLR)-2, 3 or 7/8 agonists 11. During early HIV-infection, NK cells
demonstrated significantly higher activation (p=0.03), expression of Killer-cell
immunoglobulin-like Receptors (KIR) (p=0.006) and expression of chemokine
receptor 7 (CCR7, p<0.0001) compared with prior to acquisition. Although NK
cells had reduced cytolytic potential following HIV acquisition, antiviral IFN-γ
secretion appeared to be preserved. NK cell responses were not different
between tenofovir and placebo gel recipients, but women who acquired HIV
whilst using tenofovir gel had higher gag-specific IFN-γ CD4+ T-cell
responses during early infection.
Overall, the findings suggest that the frequency of NK cells producing IFN-γ
specifically after co-culture with HIV-1 infected target cells was associated
with protection from HIV-1 acquisition but, generalised, non-specific activation
of NK cells and other innate immune components enhanced HIV acquisition.
Since neither microbial translocation nor TLR responsiveness were
associated with pre-existing immune activation further studies will be required
to identify the drivers of generalised innate immune activation. Methods to
dampen generalised innate immune activation and/or augment specific NK
cell antiviral responses in women at risk for HIV-1 may reduce HIV-1
acquisition.
During primary HIV-1 infection, NK cells underwent impairment of cytolytic
function but not IFN-γ secretory function; this may affect their ability to affect
disease progression. Although Tenofovir gel did not alter innate immune
responses in women with breakthrough infection, it preserved HIV-specific Tcell
immune responses, the consequences of which need further exploration.
Understanding how Tenofovir gel mediated preservation of adaptive immune
responses may lead to interventions that will reinforce protective host
responses.
In conclusion, innate immune responses by NK cells have been shown to
impact HIV acquisition; HIV-specific IFN-γ responses by NK cells were
protective while generalised NK activation was detrimental. The causes of
innate immune activation are not known but these effects were independent of
the impact of Tenofovir gel. Future prevention strategies targeting mucosal
transmission of HIV should assess their impact on NK cell responses, to avoid
general innate immune activation and enhance their ability to protect against HIV acquisition. / Thesis (Ph.D.)-University of KwaZulu-Natal, Durban, 2013.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:ukzn/oai:http://researchspace.ukzn.ac.za:10413/10857 |
| Date | January 2013 |
| Creators | Naranbhai, Vivek. |
| Contributors | Abdool Karim, Salim Safurdeen., Carr, William Henry. |
| Source Sets | South African National ETD Portal |
| Language | en_ZA |
| Detected Language | English |
| Type | Thesis |
Page generated in 0.0039 seconds